American Diabetes Association position statement: standards of medical care in diabetes 2006.
Diabetes Care.
2006;29:S4-S42.
American Heart Association says diabetes is a major risk factor for heart disease and stroke.
Stroke News. September 11, 1999. American Heart Association website. Available at:
. Accessed October 14, 2003.
Diabetes complications and related concerns. American Diabetes Association website. Available at:
. Accessed October 13, 2003.
Diabetes and hearing loss. American Diabetes Association website. Available at: . Accessed December 5, 2011.
Diabetes and oral health problems. American Diabetes Association website. Available at: . Accessed December 5, 2011.
Diabetic neuropathies: the nerve damage of diabetes. National Diabetes Information Clearinghouse (NDIC) website. Available at:
. Accessed October 14, 2003.
Eye care and retinopathy. American Diabetes Association website. Available at:
. Accessed October 13, 2003.
Eye complications.
American Diabetes Association
website. Available at:
. Accessed December 5, 2011.
Gross JL, de Azevedo, Silveviro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment.
Diabetes Care. 2005;28:176-88.
Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial.
Lancet. 2002;360:7-22.
Kendall DM, Riddle MC, Rosenstock J, et al. Effects of Exenatide (Exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.
Diabetes Care. 2005;28:1083-91.
Kidney disease (nephropathy). American Diabetes Association website. Available at:
. Accessed December 5, 2011.
Kris-Etherton PM, Harris WS, Appel LJ for the AHA Nutrition committee:Omega-3 Fatty Acids and Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2003; 23:151-52.
Link for life: an interactive program on diabetes and heart disease. American Diabetes Association website. Available at:
. Accessed October 13, 2003.
Lipid control in the management of type 2 diabetes mellitus: a clinical guideline from the American College of Physicians.
Annals Internal Med. 2004; 140:644-9.
Living with type 2 diabetes. American Diabetes Association website. Available at:
. Accessed October 13, 2003.
Molitch ME, DeFranzo, Franz MJ, et al. Diabetic nephrophathy.
Diabetes Care. 2003; 26 (Supp 1):S94-8.
Moor H, Summerbell C, Hooper L, et al: Dietary advice for treatment of type 2 diabetes mellitus in adults.
The Cochrane Database of Systematic Reviews. 2004;2.
National Institute of Diabetes and Digestive and Kidney Diseases, National
Institutes of Health website. Available at:
. Accessed February 8, 2006.
Peripheral neuropathy. American Diabetes Association website. Available at:
. Accessed December 5, 2011.
Prevent diabetes problems: keep your diabetes under control. National Diabetes Information Clearinghouse (NDIC) website. Available at:
. Accessed October 14, 2003.
Skin problems. American Diabetes Association website. Available at: . Accessed December 5, 2011.
Skyler JS, Bergenstal R, Bonow RO et al. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials.
Circulation.
2009;119:351-357.
Stroke. American Diabetes Association website. Available at: . Accessed December 5, 2011.
2/7/2008 DynaMed Systematic Literature Surveillance
: Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients.
Am J Med.
2007;120:1042-1046.
2/7/2008 DynaMed Systematic Literature Surveillance
: Lavery LA, Higgins KR, Lanctot DR, et al. Home monitoring of foot skin temperatures to prevent ulceration.
Diabetes Care.
2004;27:2642-2647.
2/13/2008 DynaMed Systematic Literature Surveillance
: For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease. NIH News. National Institutes of Health website. Available at:
. Accessed February 13, 2008.
2/21/2008 DynaMed Systematic Literature Surveillance
: Major international diabetes study does not confirm increased risk of death reported by US trial. Action in Diabetes and Vascular Disease: PreteraAx and DiamicroN MR Controlled Evaluation (ADVANCE) website. Available at:
. Accessed February 21, 2008.
4/10/2008 DynaMed Systematic Literature Surveillance
: The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med.
2008 Mar 31 [Epub ahead of print].
6/18/2008 DynaMed Systematic Literature Surveillance
: ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
N Engl J Med.
2008;358:2560-2572. Epub 2008 Jun 6.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.